|4Mar 23, 12:24 PM ET

Erlander Mark 4

4 · Cardiff Oncology, Inc. · Filed Mar 23, 2021

Insider Transaction Report

Form 4
Period: 2021-03-23
Erlander Mark
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2021-03-23$10.34/sh+965$9,98014,481 total

Documents

1 file
  • 4
    wf-form4_161651662768276.xmlPrimary

    FORM 4